Pycnogenol

Authors: Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 26.07.2025

Dieser Artikel auf Deutsch

Synonym(s)

4-hydroxycatechin; CAS No.: 489-17-1; Leukocyanidin; Pycogenol

Definition
This section has been translated automatically.

Natural substance from the group of leucoanthocyanidins or catechins. The substance is extracted from the bark of the pine tree, mostly from the French maritime pine - Pinus pinaster atlantica. Pycnogenol is soluble in water and ethanol but insoluble in ether.

In randomized, double-blind, placebo-controlled clinical studies, positive effects on cardiovascular health, chronic venous insufficiency, cognition, joints, skin, eyes, respiratory tract and allergies, and athletic performance have been demonstrated.

In bronchial asthma, Pycnogenol® plus inhaled croticosteroids showed a statistically significant improvement compared to the control group that only used inhaled steroids (Belcaro G et al. (2011)

Effects
This section has been translated automatically.

Antioxidant, anti-edematous, antithrombotic, antihypertensive, antiallergic

Field of application/use
This section has been translated automatically.

Pycogenol for osteoarthritis: 3 major clinical studies have shown that taking pine bark extract improves osteoarthritic symptoms. The dosage for the commercial preparation "Pycnogenol®" is 100 mg to 150 mg pycogenol p.o./day.

Pycogenol in bronchial asthma: Both clinical and experimental studies postulate an anti-allergic and anti-inflammatory effect with improvement of pre-existing bronchial asthma.

Pycogenol in thrombosis: In a study of 198 passengers on long-haul flights, the effect of pine bark extract on the risk of thrombosis was investigated 15. The study participants received either 2 x 100 mg p.o. Pycogenol or placebo 2-3 h before departure. The sonographically determined thrombosis rate was significantly reduced by taking Pycogenol (see alsoTraveler's thrombosis).

Pycogenol in chronic venous insufficiency (CVI ): Several studies relate to chronic venous insufficiency (CVI). There was evidence of an improvement in leg swelling.

Literature
This section has been translated automatically.

  1. Arcangeli (2000) Pycnogenol in chronic venous insufficiency. Fitoterapia 71:236-44.
  2. Belcaro Get al.(2004) Prevention of venous thrombosis and thrombophlebitis in long-haul flights with pycnogenol. Clin Appl Thromb Hemost 10:373-377.
  3. Faird R et al. (2007) Pycnogenol® supplementation reduces pain and stiffness and improves physical function in adults with knee osteoarthritis. Nutr Res 27: 692-697
  4. Hosseini S et al.(2001) Pycnogenol((R)) in the Management of Asthma.J Med Food 4:201-209.
  5. Hosseini et al (2001) A randomized, double-blind, placebo controlled, prospective 16 weeks crossover study to determine the role of Pycnogenol in modifying blood pressure in mildly hypertensive patients. Nutr Res 21:67-76.
  6. Jerez et al (2007) A comparison between bark extracts from Pinus pinaster and Pinus radiata: Antioxidant activity and procyanidin composition. Food Chemistry 100: 439-444
  7. Koch R (2002) Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency.Phytother Res 16 Suppl 1:S1-5.
  8. Weichmann F et al. (2024) Pycnogenol® French maritime pine bark extract in randomized, double-blind, placebo-controlled human clinical studies. Front Nutr 2;11:1389374. doi: 10.3389/fnut.2024.1389374. PMID: 38757130; PMCID: PMC11096518.
  9. Belcaro G et al. (2011) Pycnogenol® improvements in asthma management. Panminerva Med;53(3 Suppl 1):57-64. PMID: 22108478.

Incoming links (2)

Maritime pine; Pine bark extract;